Retraction notices

Worsening of Pre-Existing Valvulopathy With A New Obesity Drug Lorcaserin, A Selective 5-Hydroxytryptamine 2C Receptor Agonist: A Meta-Analysis of Randomized Controlled Trials

Type

Retraction

Notice date

11/4/2013 0:00

Journal

Journal of the American College of Cardiology (JACC)

Publisher

Elsevier

Notice DOI

10.1016/j.jacc.2013.10.003

Original paper DOI

10.1016/s0735-1097(13)61542-9

Reasons

• Error in Analyses
• Error in Data
• Error in Methods
• Error in Results and/or Conclusions